首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR INHIBITION OF INTERLEUKIN-2- -DEPENDENT TUMOR CELLS PROLIFERATION, --INTERFERON CONTENT INCREASE, TREATMENT OF PATIENTS WITH INTESTINE INFLAMMATORY DISEASES, INHIBITION POTENTIATION OF CYTOKINE PRODUCTION AND LIMITATION OR INHIBITION OF ALLERGIC RESPONSE OF DELAYED TYPE

PHARMACEUTICAL COMPOSITION FOR INHIBITION OF INTERLEUKIN-2- -DEPENDENT TUMOR CELLS PROLIFERATION, --INTERFERON CONTENT INCREASE, TREATMENT OF PATIENTS WITH INTESTINE INFLAMMATORY DISEASES, INHIBITION POTENTIATION OF CYTOKINE PRODUCTION AND LIMITATION OR INHIBITION OF ALLERGIC RESPONSE OF DELAYED TYPE

机译：抑制白细胞介素2依赖性肿瘤细胞增殖，干扰素含量增加，治疗患有肠炎性疾病的患者，抑制细胞因子产生的抑制作用和抑制或抑制所有类型疾病的药物组合物

页面导航

摘要
著录项
相似文献

摘要

FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical composition has at least one pharmaceutically acceptable carrier and an active substance taken from a group involving interleukin-4, interleukin-10, combination of interleukin-4 and interleukin-10 and antibodies against interleukin-4 and interleukin-10 taken at an effective amount. EFFECT: enhanced effectiveness of composition. 6 cl, 14 tbl

机译：领域：医学，药学。物质：药物组合物具有至少一种药学上可接受的载体和活性物质，所述活性物质选自白细胞介素-4，白细胞介素10，白细胞介素4和白细胞介素10的组合以及抗白细胞介素4和白细胞介素10的抗体。有效量。效果：增强了合成效果。 6厘升，14汤匙

著录项

公开/公告号RU2120802C1

专利类型
公开/公告日1998-10-27

原文格式PDF
申请/专利权人 SHERING KORPOREJSHN (US);
展开▼

申请/专利号RU19950108330
发明设计人 ROBERT KOFFMEN (US);JAN DE FRIS (NL);RENE DEE VAAL MALEFIT (NL);FIONA PAURI (GB);DONA RENNIK (US);
展开▼

申请日1993-08-18
分类号A61K38/20;A61K39/395;
国家 RU
入库时间 2022-08-22 02:45:00

相似文献

专利
外文文献
中文文献